As organizations focus on finding the most efficient pathways to market and provide patients with rapid access to novel treatments, they face a variety of regulatory hurdles. These challenges are influenced not only by regional regulatory developments but also by a company’s global footprint, the size and capabilities of regulatory teams, resource limitations and the target markets for commercialization.